HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosa Resende Selected Research

Alzheimer Disease (Alzheimer's Disease)

7/2021Structural and Functional Alterations in Mitochondria-Associated Membranes (MAMs) and in Mitochondria Activate Stress Response Mechanisms in an In Vitro Model of Alzheimer's Disease.
10/2020Calcium Modulation, Anti-Oxidant and Anti-Inflammatory Effect of Skin Allergens Targeting the Nrf2 Signaling Pathway in Alzheimer's Disease Cellular Models.
1/2020New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.
4/2015Alzheimer's disease-related misfolded proteins and dysfunctional organelles on autophagy menu.
6/2014Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer's disease.
4/2013Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease.
6/2010Cholesterol and statins in Alzheimer's disease: current controversies.
1/2009Neuroprotective effects of statins in an in vitro model of Alzheimer's disease.
6/2008Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
9/2006An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosa Resende Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
07/2021 - 09/2006
5Neurodegenerative Diseases (Neurodegenerative Disease)
10/2020 - 06/2008
4Inflammation (Inflammations)
02/2024 - 03/2022
2Mitochondrial Diseases (Mitochondrial Disease)
02/2024 - 04/2015
2Neuroinflammatory Diseases
08/2022 - 10/2020
2Amyloid Plaque
04/2013 - 06/2008
1Brain Diseases (Brain Disorder)
10/2022
1Autistic Disorder (Autism)
08/2022
1Bipolar Disorder (Manic Depressive Psychosis)
03/2022
1Neuroblastoma
07/2021
1Lewy Body Variant of Alzheimer Disease
04/2013
1Dementia (Dementias)
06/2010
1Cognitive Dysfunction
06/2008

Drug/Important Bio-Agent (IBA)

5Amyloid (Amyloid Fibrils)IBA
07/2021 - 04/2013
5Peptides (Polypeptides)IBA
01/2020 - 09/2006
4Amyloid beta-PeptidesIBA
04/2013 - 09/2006
3Proteins (Proteins, Gene)FDA Link
07/2021 - 06/2014
2LipidsIBA
02/2024 - 10/2022
2AntioxidantsIBA
10/2020 - 06/2008
2CholesterolIBA
06/2010 - 01/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2010 - 01/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022
1Sigma-1 ReceptorIBA
10/2022
1Anthocyanins (Anthocyanin)IBA
08/2022
1Serotonin (5 Hydroxytryptamine)IBA
08/2022
1Valproic Acid (Depakote)FDA LinkGeneric
08/2022
1InflammasomesIBA
03/2022
1LipopolysaccharidesIBA
10/2020
1CalciumIBA
10/2020
1Tuberculin (PPD)IBA
10/2020
1AllergensIBA
10/2020
1Dimethyl FumarateIBA
10/2020
14-phenylenediamine (p-phenylenediamine)FDA Link
10/2020
1methyl heptine carbonateIBA
10/2020
1Cysteine (L-Cysteine)FDA Link
10/2020
1tau Proteins (tau Protein)IBA
04/2015
12,3,4,4- tetramethyl- 5- methylenecyclopent- 2- enoneIBA
06/2014
1Monoterpenes (Monoterpenoids)IBA
06/2014
1Peptide Hydrolases (Proteases)FDA Link
06/2014
1SynucleinsIBA
04/2013
1Neuroprotective AgentsIBA
01/2009
1PrionsIBA
09/2006

Therapy/Procedure

1Therapeutics
01/2020